FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program

Kushal T. Kadakia, Sanket S. Dhruva, Joseph S. Ross, James F. Burke, James L. Johnston, Reshma Ramachandran, Harlan M. Krumholz, Vinay K. Rathi

Open source

DOI: 10.1001/jamainternmed.2025.2235
Published: 2025-08-01
Container: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2025.2235,
  title = {FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program},
  author = {Kushal T. Kadakia and Sanket S. Dhruva and Joseph S. Ross and James F. Burke and James L. Johnston and Reshma Ramachandran and Harlan M. Krumholz and Vinay K. Rathi},
  year = {2025},
  journal = {JAMA Internal Medicine},
  doi = {10.1001/jamainternmed.2025.2235},
  url = {https://doi.org/10.1001/jamainternmed.2025.2235}
}

RIS

TY  - JOUR
TI  - FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program
AU  - Kushal T. Kadakia
AU  - Sanket S. Dhruva
AU  - Joseph S. Ross
AU  - James F. Burke
AU  - James L. Johnston
AU  - Reshma Ramachandran
AU  - Harlan M. Krumholz
AU  - Vinay K. Rathi
PY  - 2025
JO  - JAMA Internal Medicine
DO  - 10.1001/jamainternmed.2025.2235
UR  - https://doi.org/10.1001/jamainternmed.2025.2235
ER  -

APA

Kadakia, K. T., Dhruva, S. S., Ross, J. S., Burke, J. F., Johnston, J. L., Ramachandran, R., Krumholz, H. M., & Rathi, V. K. (2025). FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.2235

Source records

crossref · retrieved 2026-09-27T04:43:43.813Z